Brown Brothers Harriman & CO Bridge Bio Pharma, Inc. Transaction History
Brown Brothers Harriman & CO
- $12.7 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding BBIO
# of Institutions
292Shares Held
175MCall Options Held
8.66MPut Options Held
2.76M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY31.1MShares$775 Million45.4% of portfolio
-
Viking Global Investors LP25.1MShares$627 Million2.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.1MShares$351 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$310 Million0.01% of portfolio
-
Aisling Capital Management LP New York, NY6.07MShares$151 Million67.33% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $3.7B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...